CDK12 and acute myeloid leukemia: shRNA-mediated knockdown of Cdk12 using three individual shRNAs caused a strong proliferative disadvantage in NUP98::KDM5A-driven AML cells, highlighting the dependency of these cells on CDK12 (Fig. 6C).